Cargando…
Potential diagnostic biomarkers for schizophrenia
Schizophrenia (SCH) is a complex and severe mental disorder with high prevalence, disability, mortality and carries a heavy disease burden, the lifetime prevalence of SCH is around 0.7%–1.0%, which has a profound impact on the individual and society. In the clinical practice of SCH, key problems suc...
Autores principales: | Yue, Weihua, Huang, Hailiang, Duan, Jubao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388817/ https://www.ncbi.nlm.nih.gov/pubmed/37724326 http://dx.doi.org/10.1515/mr-2022-0009 |
Ejemplares similares
-
Cell type-specific and cross-population polygenic risk score analyses of MIR137 gene pathway in schizophrenia
por: Yao, Yin, et al.
Publicado: (2021) -
From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies
por: Duan, Jubao, et al.
Publicado: (2019) -
Cell-Type-Specific Proteogenomic Signal Diffusion for Integrating Multi-Omics Data Predicts Novel Schizophrenia Risk Genes
por: Doostparast Torshizi, Abolfazl, et al.
Publicado: (2020) -
The Biomarker and Therapeutic Potential of Circular Rnas in Schizophrenia
por: Nedoluzhko, Artem, et al.
Publicado: (2020) -
Theranostic Biomarkers for Schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2017)